Quarterly report pursuant to sections 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v2.4.0.6
Consolidated Balance Sheets (Unaudited) (USD $)
Mar. 31, 2013
Dec. 31, 2012
Current assets:    
Cash $ 2,916,476 $ 2,354,169
Marketable securities - available for sale securities 6,250 12,500
Prepaid expenses 30,666 40,333
Assets of discontinued operations - current portion 53,395 82,145
Total current assets 3,006,787 2,489,147
Other assets:    
Property and equipment, net 9,722   
Intangible assets, net 474,605 492,152
Assets of discontinued operations - long term portion 230,088 1,035,570
Total other assets 714,415 1,527,722
Total Assets 3,721,202 4,016,869
Current liabilities:    
Accounts payable and accrued expenses 153,169 57,158
Liabilities of discontinued operations 30,664 30,664
Total liabilities 183,833 87,822
Stockholders' Equity:    
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding      
Common stock, ($.0001 par value; 200,000,000 shares authorized; 45,546,345 and 45,546,345 issued and outstanding at March 31, 2013 and December 31, 2012 4,555 4,555
Additional paid-in capital 11,192,230 10,972,122
Accumulated other comprehensive income - marketable securities available for sale (6,250)   
Deficits accumulated during the development stage (7,642,670) (7,037,134)
Total Marathon Patent Group, Inc. equity 3,547,865 3,939,543
Non-controlling interest in subsidiary (10,496) (10,496)
Total stockholders' equity 3,537,369 3,929,047
Total liabilities and stockholders' equity $ 3,721,202 $ 4,016,869